病毒学
细胞毒性T细胞
人类免疫缺陷病毒(HIV)
病毒
CD8型
免疫学
生物
医学
免疫系统
生物化学
体外
作者
Mathieu Angin,Glenn Wong,Laura Papagno,Pierre Versmisse,Annie David,Charles Bayard,Bénédicte Charmeteau-De Muylder,Amel Besseghir,Rodolphe Thiébaut,Faroudy Boufassa,Gianfranco Pancino,Delphine Sauce,Olivier Lambotte,Françoise Brun‐Vézinet,Sophie Matheron,Sarah Rowland‐Jones,Rémi Cheynier,Asier Sáez‐Cirión,Victor Appay
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2016-08-27
卷期号:197 (7): 2787-2795
被引量:22
标识
DOI:10.4049/jimmunol.1600693
摘要
Abstract Compared with HIV-1, HIV-2 infection is characterized by a larger proportion of slow or nonprogressors. A better understanding of HIV-2 pathogenesis should open new therapeutic avenues to establish control of HIV-1 replication in infected patients. In this study, we studied the production of CD8+ T cells and their capacity for viral control in HIV-2 controllers from the French ANRS CO5 HIV-2 cohort. HIV-2 controllers display a robust capacity to support long-term renewal of the CD8+ T cell compartment by preserving immune resources, including hematopoietic progenitors and thymic activity, which could contribute to the long-term maintenance of the CD8+ T cell response and the avoidance of premature immune aging. Our data support the presence of HIV-2 Gag–specific CD8+ T cells that display an early memory differentiation phenotype and robust effector potential in HIV-2 controllers. Accordingly, to our knowledge, we show for the first time that HIV-2 controllers possess CD8+ T cells that show an unusually strong capacity to suppress HIV-2 infection in autologous CD4+ T cells ex vivo, an ability that likely depends on the preservation of host immune resources. This effective and durable antiviral response probably participates in a virtuous circle, during which controlled viral replication permits the preservation of potent immune functions, thus preventing HIV-2 disease progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI